Vancomycin-Associated Nephrotoxicity

Status Completed

Clinical Trial Summary

The primary goal of this study is to determine if there is an association between greater exposure to vancomycin and the development of nephrotoxicity. The secondary goal is to estimate the costs to the hospital associated with these nephrotoxic events.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Nephrotoxicity

Clinical Trial Details

NCT number	NCT01216540
Study type	Observational
Source	University at Buffalo
Contact
Status	Completed
Phase
Start date	November 2010
Completion date	April 2011

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT06360666` - Clinical Outcomes in Adult Patients Undergoing Laparoscopic Surgery Under Neuraxial Anesthesia
Recruiting	`NCT01624324` - Aminoglycoside Plasma Level Measurement in Neonates With Infection	N/A
Recruiting	`NCT03817970` - Cisplatin Disposition and Kidney Injury	Phase 3
Completed	`NCT01467154` - Evaluation of Intravenous N-acetylcysteine to Prevent Contrast Media Induced Nephrotoxicity in an Emergency Center	N/A
Recruiting	`NCT03480971` - Treatment of Radiation and Cisplatin Induced Toxicities With Tempol	Phase 2
Recruiting	`NCT02528448` - 0,9% NaCl Effect on Kidney Function and Glycocalyx in Patients Operated on for Primary Hiparthrosis	Phase 4
Completed	`NCT02103855` - Switch From Calcineurin Inhibitor to Belatacept in Pancreas Transplant Recipients	Phase 4
Recruiting	`NCT06153147` - KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors (CCS)
Completed	`NCT04354467` - Assessment of Urinary Neutrophil Gelatinase-Associated Lipocalin to Predict AKI in the NICU
Recruiting	`NCT05673824` - Effect of Huaier Granule on Nephrotoxicity Associated With Targeted Therapy for Advanced Hepatobiliary Malignancies.	Phase 4
Not yet recruiting	`NCT03438214` - Effect of Intermittent Infusion Versus Continuous Infusion of Vancomycin on Kidney Failure in Critically Ill Patients	Phase 4
Completed	`NCT03527160` - Assessment of Urinary NGAL to Predict AKI in Children Receiving Multiple Nephrotoxic Medications
Completed	`NCT01848457` - Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy	Phase 2